However, a noteworthy finding from the TIMER2.0 database revealed that NSCLC patients exhibiting both high BIN1 and high CD8 expression demonstrated significantly improved OS compared to those with high BIN1 but low CD8 expression (Fig. 1f). Here, CD8A is linked to non-small cell lung carcinoma.